(HealthDay)—Treatment with a dual wavelength non-ablative fractional laser may result in the functional improvement of scar contractures, according to a case study published online Aug. 6 in Lasers in Surgery and Medicine.
Aug 20, 2015
0
6
(HealthDay)—Forty percent of patients with primary prevention implantable cardioverter-defibrillators (ICDs) experience improvement in left ventricular ejection fraction (LVEF), according to a study published in the Aug. ...
Jul 30, 2015
0
5
(HealthDay)—For patients with pulmonary hypertension associated with heart failure and preserved ejection fraction (PH-HFpEF), the six-minute walk distance (6-MWD) test can independently predict outcome, according to a ...
Jun 3, 2015
0
5
(HealthDay)—A simple age, creatinine, and ejection fraction (ACEF) score can predict one-year mortality risk in myocardial infarction 30-day survivors who underwent percutaneous coronary intervention, according to a study ...
Apr 20, 2015
0
3
Patients who receive more cells get significant benefits. That's a key lesson emerging from a clinical trial that was reported this week at the American Heart Association meeting in Chicago.
Nov 21, 2014
0
0
(HealthDay)—Non-ablative fractional laser treatment may provide long-term improvement of mature burn scars, according to research published online Aug. 22 in Lasers in Surgery and Medicine.
Sep 12, 2014
0
0
Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not ...
Apr 9, 2014
0
0
A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly ...
Apr 2, 2014
0
1
Two drugs tested in a larger trial did not improve kidney function in acute heart failure patients, contrary to results of smaller studies. The results were presented today at the American Heart Association's Scientific Sessions ...
Nov 18, 2013
0
0
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, ...
Nov 18, 2013
0
0
